Effect of infliximab on quality of life in patients with ankylosing spondylitis according to sf-36 questionnaire data
Objective: to evaluate the effect of infliximab (INF) on quality of life (QL) in patients with ankylosing spondylitis (AS), by analyzing the results of a SF-36 questionnaire survey. Subjects and methods. Sixty-six male patients, diagnosed with AS (according to the 1984 modified New-York criteria) in...
Main Authors: | Tatyana Alekseevna Raskina, O A Pirogova, Zh A Pivovarova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2013-10-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/495 |
Similar Items
-
Use of inhibitors of tumor necrosis factor α in women with ankylosing spondylitis
by: O. A. Krichevskaya, et al.
Published: (2021-10-01) -
The abilities of golimumab in the therapy of ankylosing spondylitis
by: Sh. F. Erdes
Published: (2014-09-01) -
Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2016-09-01) -
The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
by: Yu. V. Muravyev, et al.
Published: (2020-05-01) -
Golimumab in the treatment of extra-skeletal manifestations of ankylosing spondylitis
by: A. B. Demina
Published: (2019-10-01)